References PubMed ID in brackets 1. Harrington SE, Smith TJ. The role of chemo<strong>the</strong>rapy at <strong>the</strong> end of life: “when is enough, enough?” JAMA 2008;299(22):2667–2678. 2. Koedoot CG, Oort FJ, de Haan RJ, Bakker PJ, de Graeff A, de Haes JC. The content and amount of information given by medical oncologists when telling patients with advanced cancer what <strong>the</strong>ir treatment options are. Palliative chemo<strong>the</strong>rapy and watchful-waiting. Eur J Cancer 2004;40(2):225–235. 3. Sullivan AM, Lakoma MD, Matsuyama RK, Rosenblatt L, Arnold RM, Block SD. Diagnosing and discussing imminent death in <strong>the</strong> hospital: a secondary analysis of physician interviews. J Palliat Med 2007;10(4):882–893. 4. Daugherty CK, Hlubocky FJ. What are terminally ill cancer patients told about <strong>the</strong>ir expected deaths? A study of cancer physicians’ self-reports of prognosis disclosure. J Clin Oncol 2008;26(36):5988–5993. 5. Wright AA, Zhang B, Ray A, Mack JW, Trice E, Balboni T, Mitchell SL, Jackson VA, Block SD, Maciejewski PK, Prigerson HG. Associations between end-of-life discussions, patient mental health, medical care near death, and caregiver bereavement adjustment. JAMA 2008;300(14): 1665–1673. 6. Zhang B, Wright AA, Huskamp HA, Nilsson ME, Maciejewski ML, Earle CC, Block SD, Maciejewski PK, Prigerson HG. Health care costs in <strong>the</strong> last week of life: associations with end-of-life conversations. Arch Intern Med 2009;169(5): 480–488. 7. Lamont EB, Christakis NA. Prognostic disclosure to patients with cancer near <strong>the</strong> end of life. Ann Intern Med 2001;134(12):1096–1105. 8. Christakis N. Death Foretold: Prophecy and Prognosis in Medical Care. Chicago: University of Chicago Press; 1999. 9. Swisher KN, Ulmer DL, Carpenter W, Mitchell RB, Wan TH, Dowdy M, Smith TJ. Patient indemnification as a way to involve patients in economic decision-making about <strong>the</strong>ir care: barriers in <strong>the</strong> current system. Proc ASCO 1996: 939a. 10. Siminoff LA, Gordon NH, Silverman P, Budd T, Ravdin PM. A decision aid to assist in adjuvant <strong>the</strong>rapy choices for breast cancer. Psychooncology 2006;15(11):1001–1013. 11. Peele PB, Siminoff LA, Xu Y, Ravdin PM. Decreased use of adjuvant breast cancer <strong>the</strong>rapy in a randomized controlled trial of a decision aid with individualized risk information. Med Decis Making 2005;25(3):301–307. 12. Smith TJ. Tell it like it is. J Clin Oncol 2000;18;3441–3445. 13. Herth K. Abbreviated instrument to measure hope: development and psychometric evaluation. J Adv Nurs 1992;17(10):1251– 1259. 14. Higginson IJ, Donaldson N. Relationship between three palliative care outcome scales. Health Qual Life Outcomes 2004;2:68. 15. Murray MA, Miller T, Fiset V, O’Connor A, Jacobsen MJ. Decision support: helping patients and families to find a balance at <strong>the</strong> end of life. Int J Palliat Nurs 2004;10(6):270–277. 16. Woolf SH, Chan EC, Harris R, Sheridan SL, Braddock CH 3rd, Kaplan RM, Krist A, O’Connor AM, Tunis S. Promoting informed choice: transforming health care to dispense knowledge for decision making. Ann Intern Med 2005;143(4): 293–300. 17. O’Connor AM, Stacey D, Entwistle V, Llewellyn-Thomas H, Rovner D, Holmes-Rovner M, Tait V, Tetroe J, Fiset V, Barry M, Jones J. Decision aids for people facing health treatment or screening decisions. Cochrane Database Syst Rev 2003;(2):CD001431. 18. Smith TJ, Dow LA, Virago E, Khatcheressian J, Lyckholm L, Matsuyama R. Giving honest information to patients with advanced cancer maintains hope. Oncologist (Williston Park) 24(6):521–525. 19. Tulsky JA, Chesney MA, Lo B. How do medical residents discuss resuscitation with patients? J Gen Intern Med 1995;10(8):436– 442. 20. Smith TJ, Desch CE, Hackney MH, Shaw JE. How long does it take to get a “do not resuscitate” order? J Palliat Care 1997;13(1):5–8. 21. Whelan TJ, Loprinzi CL. Physician/patient decision aids for adjuvant <strong>the</strong>rapy. J Clin Oncol 2005;23:1627–1630. 22. Whelan TM, O’Brien MA, Villasis-Keever M, et al. Impact of Cancer-Related Decision Aids. Evidence Report/Technology Assessment Number 46. (Prepared by McMaster University under contract no. 290-97-0017.) AHRQ Publication 02- E004, Rockville, MD: Agency for Healthcare Research and Quality; 2002. 23. Cassileth BR, Soloway MS, Vogelzang NJ, et al. Patients’ choice of treatment in stage D prostate cancer. Urology 1989;33(suppl 5):S57– S62. 24. Chadwick DJ, Gillatt DA, Gingell JC. Medical or surgical orchidectomy: The patients’ choice. BMJ 302:572, 1991. 25. Elit LM, Levine MN, Gafni A, et al. Patients’ preferences for <strong>the</strong>rapy in advanced epi<strong>the</strong>lial ovarian cancer: Development, testing, and application of a bedside decision instrument. Gynecol Oncol 62:329–335, 1996. 26. Fiset V, O’Connor AM, Evans W, et al. Development and evaluation of a decision aid for patients with stage IV non-small cell lung cancer. Health Expect 3:125–136, 2000. 27. Brundage MD, Feldman-Steward D, Cosby R, et al. Cancer patients’ attitudes toward treatment options for advanced non-small cell lung cancer: Implications for patient education and decision support. Patient Educ Couns 45: 149–157, 2001. 28. Brundage MD, Feldman-Stewart D, Cosby R, et al. Phase I study of a decision aid for patients with locally advanced non-smallcell lung cancer. J Clin Oncol 19:1326–1335, 2001. 29. Chiew KS, Shepherd H, Vardy J, Tattersall MH, Butow PN, Leighl NB. Development Smith, Dow, Virago, et al and evaluation of a decision aid for patients considering first-line chemo<strong>the</strong>rapy for metastatic breast cancer. Health Expect 2008;11(1): 35–45. 30. Mackillop WJ, Stewart WE, Ginsburg AD, Stewart SS. Cancer patients’ perceptions of <strong>the</strong>ir disease and its treatment. Br J Cancer 1988;58: 355–358. 31. Chow E, Andersson L, Wong R, Vachon M, Hruby G, Franssen E, et al. Patients with advanced cancer: a survey of <strong>the</strong> understanding of <strong>the</strong>ir illness and expectations <strong>from</strong> palliative radio<strong>the</strong>rapy for symptomatic metastases. Clin Oncol (R Coll Radiol) 2001;13:204– 208. 32. Ganti AK, Lee SJ, Vose JM, Devetten MP, Bociek RG, Armitage JO, Bierman PJ, Maness LJ, Reed EC, Loberiza FR Jr. Outcomes after hematopoietic stem-cell transplantation for hematologic malignancies in patients with or without advance care planning. J Clin Oncol 2007;25(35):5643–5648. 33. Lee SJ, Fairclough D, Antin JH, Weeks JC. Discrepancies between patient and physician estimates for <strong>the</strong> success of stem cell transplantation. JAMA 2001;285(8):1034–1038. 34. Lee SJ, Loberiza FR, Rizzo JD, Soiffer RJ, Antin JH, Weeks JC. Optimistic expectations and survival after hematopoietic stem cell transplantation. Biol Blood Marrow Transplant 2003;9: 389–396. 35. Weeks JC, Cook EF, O’Day SJ, Peterson LM, Wenger N, Reding D, et al. Relationship between cancer patients’ predictions of prognosis and <strong>the</strong>ir treatment preferences. JAMA 1998; 279(21):1709–1714. 36. Earle CC, Neville BA, Landrum MB, Ayanian JZ, Block SD, Weeks JC. Trends in <strong>the</strong> aggressiveness of cancer care near <strong>the</strong> end of life. J Clin Oncol 2004;22(2):315–321. 37. Matsuyama R, Reddy SN, Smith TJ. Why do patients choose chemo<strong>the</strong>rapy near <strong>the</strong> end of life? J Clin Oncol 2006;24:1–7. 38. Dufresne A, Pivot X, Tournigand C, Facchini T, Altweegg T, Chaigneau L, De Gramont A. Impact of chemo<strong>the</strong>rapy beyond <strong>the</strong> first line in patients with metastatic breast cancer. Breast Cancer Res Treat 2008;107(2):275–279. 39. Kirk P, Kirk I, Kristjanson LJ. What do patients receiving palliative care for cancer and <strong>the</strong>ir families want to be told? A Canadian and Australian qualitative study. BMJ 2004; 328(7452):1343. 40. Emanuel LL, Ferris FD, von Gunten CF, Von Roenn J. EPEC-O: Education in Palliative and End of Life Care for Oncology. Chicago: EPEC Project; 2005. 41. Field MJ, Cassel CK. Approaching Death: Improving Care at <strong>the</strong> End of Life. Washington DC: National Academy Press; 1997:59–64. 42. Huskamp HA, Keating NL, Malin JL, Zaslavsky AM, Weeks JC, Earle CC, Teno JM, Virnig BA, Kahn KL, He Y, Ayanian JZ. Discussions with physicians about hospice among patients VOLUME 9, NUMBER 2 � MARCH/APRIL 2011 www.SupportiveOncology.net 85
Truthful Information with metastatic lung cancer. Arch Intern Med 2009;169(10):954–962. 43. Glare P, Virik K, Jones M, Hudson M, Eychmuller S, Simes J, et al. A systematic review of physicians’ survival predictions in terminally ill cancer patients. BMJ 2003;327:195–200. 44. Smith T, Swisher K. Telling <strong>the</strong> truth about terminal cancer. JAMA 1998;279(21):1746–1748. 45. Beauchamp T, Childress J. Principles of Biomedical Ethics, 5th ed. New York: Oxford University Press; 2001. 46. Panagopoulou E, Mintziori G, Montgomery A, Kapoukranidou D, Benos A. Concealment of information in clinical practice: is lying less stressful than telling <strong>the</strong> truth? J Clin Oncol 2008;26(7): 1175–1177. 47. Fallowfield L, Jenkins V. Communicating sad, bad, and difficult news in medicine. Lancet 2004;363(9405):312–319. 48. Dow LA, Matsuyama RK, Ramakrishnan V, Kuhn L, Lamont EB, Lyckholm L, Smith TJ. Paradoxes in advance care planning: <strong>the</strong> complex relationship of oncology patients, <strong>the</strong>ir physicians, and advance medical directives. J Clin Oncol 2010;28(2):299–304. 86 www.SupportiveOncology.net THE JOURNAL OF SUPPORTIVE ONCOLOGY
Change language